1 year return (CAGR)
24.54%
Inhibrx Biosciences, Inc. Exchange (NASDAQ, USD)
INBX
73.29
-22.37 (-23.38%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
70.37%
5 year return (CAGR)
13.76%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.08B
Price/Sales
-
Ent value
1.15B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
24.58%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 94.55 |
| Daily high | 96.78 |
| Daily low | 69.27 |
| Daily Volume | 1.19M |
| All-time high | 141.84 |
| 1y analyst estimate | 266.67 |
| Beta | 3.67 |
| EPS (TTM) | -8.82 |
| Dividend per share | 0.00 |
| Ex-div date | 30 May 2024 |
| Next earnings date | 23 Mar 2026 |
Downside potential
Loading...
Downside potential data
| INBX | S&P500 | |
| Current price drop from All-time high | -48.33% | -0.87% |
| Highest price drop | -82.96% | -56.47% |
| Date of highest drop | 14 Jun 2022 | 9 Mar 2009 |
| Avg drop from high | -45.41% | -10.65% |
| Avg time to new high | 43 days | 12 days |
| Max time to new high | 1218 days | 1805 days |
News
